Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR – Get Free Report) was upgraded by research analysts at Roth Capital to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.
Separately, Roth Mkm assumed coverage on Synergy CHC Corp. (Uplisting) in a research report on Tuesday. They issued a “buy” rating and a $10.00 target price for the company.
Read Our Latest Research Report on Synergy CHC Corp. (Uplisting)
Synergy CHC Corp. (Uplisting) Trading Up 1.2 %
Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR – Get Free Report) last announced its quarterly earnings data on Friday, December 6th. The company reported $0.10 EPS for the quarter.
About Synergy CHC Corp. (Uplisting)
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.
See Also
- Five stocks we like better than Synergy CHC Corp. (Uplisting)
- Are Penny Stocks a Good Fit for Your Portfolio?
- Oracle Announces Game-Changing News for the AI Industry
- What is a Dividend King?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Why Are Stock Sectors Important to Successful Investing?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Synergy CHC Corp. (Uplisting) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergy CHC Corp. (Uplisting) and related companies with MarketBeat.com's FREE daily email newsletter.